- Published on
Emergency and Acute Medicine – Necrotizing Soft Tissue Infections
Necrotizing soft tissue infections (NSTIs) are rapidly progressive infections involving any layer of the skin and underlying soft tissues, characterized by widespread necrosis, severe systemic toxicity, and a high mortality rate. These infections spread quickly along tissue planes, often causing extensive fascial and muscle destruction with relative sparing of the skin in early stages. Clinical entities within this spectrum include necrotizing fasciitis, Fournier gangrene, clostridial and nonclostridial myonecrosis, crepitant anaerobic cellulitis, and progressive bacterial gangrene. Despite being uncommon, NSTIs carry mortality rates of 24–34% and are associated with significant morbidity such as amputations, renal failure, and prolonged critical illness.
NSTIs typically arise in the setting of local tissue trauma, ischemia, or impaired host defenses. Risk is increased in older adults, smokers, and patients with chronic systemic disease including diabetes mellitus, obesity, peripheral vascular disease, chronic kidney disease, alcohol abuse, immunosuppression, and intravenous drug use. Type I NSTIs, which account for approximately 80% of cases, are polymicrobial infections involving aerobic and anaerobic organisms and commonly occur after surgery or in patients with chronic illness. Type II NSTIs are usually monomicrobial, most often caused by group A β-hemolytic streptococcus, and can affect young, otherwise healthy individuals; these infections are the classic “flesh-eating” disease. Type III NSTIs are rare but fulminant, frequently clostridial in origin, and often follow penetrating trauma, crush injuries, or injection drug use. Pediatric cases are uncommon but may occur in neonates after omphalitis or circumcision, or in children following recent varicella infection, surgery, or in those with immunodeficiency.
The clinical presentation can be subtle early but deteriorates rapidly. Patients often report fever, malaise, altered mental status, and severe pain at the affected site. A hallmark feature is pain that is disproportionate to physical findings. Within the first 24 hours, localized swelling, warmth, erythema, and tenderness develop, followed over the next 24–48 hours by skin discoloration (purple or blue), hemorrhagic bullae, and foul-smelling, thin drainage due to necrosis of fascia and fat. Systemic toxicity is common and includes tachycardia, tachypnea, hypotension, fever, and mental status changes. Crepitus, while pathognomonic, is present in only a minority of cases. In children, localized pain and rash are the most common presenting features, while hypotension and shock are less frequent early findings.
Diagnosis is challenging and relies heavily on clinical suspicion, particularly in high-risk patients who appear severely ill or have pain out of proportion to examination findings. Laboratory abnormalities may include leukocytosis, electrolyte derangements, renal dysfunction, hypocalcemia from fat necrosis, and evidence of disseminated intravascular coagulation. Imaging studies such as plain radiographs, CT, MRI, or ultrasound may demonstrate soft tissue gas, fascial thickening, or fluid along fascial planes, but absence of these findings does not exclude NSTI. Importantly, imaging should never delay surgical intervention. Definitive diagnosis is established by surgical exploration with deep tissue biopsy and cultures, which remains the gold standard.
Management of NSTIs is a true surgical emergency. Initial stabilization focuses on airway protection, aggressive fluid resuscitation, oxygenation, and correction of metabolic disturbances. Broad-spectrum intravenous antibiotics must be initiated immediately, targeting aerobic gram-positive and gram-negative organisms, anaerobes, and methicillin-resistant Staphylococcus aureus until culture results are available. Clindamycin should be started early, particularly when group A streptococcal infection is suspected, due to its ability to suppress toxin production. However, antimicrobial therapy alone is insufficient; early and aggressive surgical debridement of all necrotic tissue with fasciotomy and drainage is the cornerstone of treatment and must not be delayed. Adjunctive therapies such as hyperbaric oxygen and intravenous immunoglobulin may be considered in select cases, though their roles remain controversial.
All patients with NSTI require hospital admission, typically to an intensive care setting, for ongoing surgical management, intravenous antibiotics, and close monitoring for complications such as acute respiratory distress syndrome, renal failure, myocardial dysfunction, and disseminated intravascular coagulation. No patient with NSTI is appropriate for discharge. Key clinical pearls include maintaining a high index of suspicion, recognizing pain out of proportion to examination as a critical clue, and understanding that mortality approaches 100% if treatment is limited to antibiotics without prompt surgical debridement.
0 Comments
